HtrA2 Antibodies

Santa Cruz Biotechnology features a diverse variety of HtrA2 monoclonal antibodies for research focused on understanding HtrA2's role in cellular processes. HtrA2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).HtrA2, also known as Omi, is a serine protease that plays a critical role in the regulation of apoptosis and mitochondrial function. HtrA2 is involved in the degradation of misfolded proteins and has been implicated in neurodegenerative diseases, making it an important target for research in cell death and survival pathways. Understanding HtrA2 function can provide insights into therapeutic strategies for conditions such as Parkinson's disease and cancer. Researchers can utilize specific monoclonal antibodies to detect HtrA2 expression patterns across different tissues and cellular compartments. Advanced imaging techniques combined with HtrA2 monoclonal antibodies enable detailed visualization of protein localization and interactions. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies for HtrA2 support researchers worldwide in advancing our understanding of cellular pathways and potential therapeutic targets.